BioSpace News Archive

Colchicine significantly reduces the risk of first and total ischemic cardiovascular events by 23% and 34% respectively in addition to standard of care in patients with a recent myocardial infarction (MI)

Results simultaneously published in the New England Journal of Medicine and presented at the American Heart Association Late-Breaking Scientific Session

November 16, 2019
·
4 min read
Pharm Country

Janssen Leverages Wearable Technology to Reimagine Clinical Trial Design

CHIEF-HF is the first-ever completely decentralized, mobile, indication-seeking study assessing effectiveness of INVOKANA® (canagliflozin) in adults with heart failure (HF), with or without type 2 diabetes (T2D)

November 16, 2019
·
17 min read
Drug Development

Kiniksa Presents Rilonacept Final Phase 2 Clinical Data at the American Heart Association Scientific Sessions 2019

Rapid resolution of both reported pain and inflammation as well as improvement in quality of life scores

November 16, 2019
·
13 min read